STATinMED
STATinMED is a Dallas-based healthcare consultancy (founded 2007) that provides real-world evidence and HEOR services to biopharmaceutical companies using a proprietary all-payer claims database covering ~80% of the US healthcare system.
- Company typePrivate
- Founded2007
- HeadquartersDallas, United States
- Headcount51–100
- GTM typeB2B
- OfferingServices
What STATinMED does
STATinMED is a Dallas-based, privately held LLC (founded 2007, 51–100 employees) operating as a real-world evidence (RWE) and health economics and outcomes research (HEOR) consultancy for healthcare and life science companies. Its core technology is STATinMED RWD Insights, a proprietary all-payer medical and pharmacy claims database sourced from clearinghouses, covering approximately 80% of the US healthcare system across 300+ million patient lives (commercial, Medicaid, Medicare FFS, and Medicare Advantage), updated monthly with a 15-day lag. In 2022 the firm extended this asset into two productized offerings — RWD Custom Registry (configurable patient-level data with time-varying metrics) and RWD Insights Direct (a branded platform for client-side data capability augmentation) — and serves clients including 22 of the Top 25 global pharmaceutical companies, with over 1,000 peer-reviewed publications across 20+ therapeutic areas and 150+ indications.
The company monetizes through professional services (HEOR, Market Access, Clinical Operations, Medical Affairs, Data Advisory, and peer-reviewed publication services) delivered via project-based engagements and direct consultative sales, supplemented by what appears to be recurring/subscription access to its RWD Insights data products. Pricing is quote-based and not publicly disclosed; the GTM motion is enterprise field sales with complimentary consultations and customized study designs. Customer segments include primary biopharmaceutical companies and secondary life-science and broader healthcare organizations, with horizontal segmentation across use cases (evidence generation, market access, clinical operations, medical affairs).
STATinMED operates under HIPAA-compliant, de-identified and tokenized data practices and has adopted GDPR controller obligations, positioning it for cross-border engagements. Marketing channels span content (peer-reviewed publications, blog), events (16+ major medical conferences annually including ISPOR, ASH, AHA, ESC), and owned social/email channels (LinkedIn, Twitter, YouTube, quarterly newsletters). Leadership includes a President (Jason Drenning, PhD), Vice Presidents for RWE (Maxine Fisher, PhD), Strategic Initiatives (Mike Rials, MS), and Finance (John Sommerhalder), plus a Senior Principal for Strategic Advisory Services. No external institutional investment, PE, or VC backing is evident, and revenue is not publicly disclosed.
STATinMED firmographics
Firmographics- Name
- STATinMED
- Legal name
- STATinMED LLC
- Website
- https://statinmed.com
- Company type
- Private
- Founded year
- 2007
- Operating status
- Operating
- Headcount range
- 51–100 employees
- Short description
- STATinMED is a Dallas-based healthcare consultancy (founded 2007) that provides real-world evidence and HEOR services to biopharmaceutical companies using a proprietary all-payer claims database covering ~80% of the US healthcare system.
- Ownership category
- akta.pro rank
STATinMED industry classification
Industry- Product category
- Healthcare Real-World Evidence and HEOR Consulting
- NAICS
- Research and Development in the Physical, Engineering, and Life Sciences (54171), Other Scientific and Technical Consulting Services (54169)
- SIC
- Services-Misc Health & Allied Services, Nec (8090), Services-Medical Laboratories (8071)
- akta.pro primary industry
- Healthcare Outcomes & Real-World Evidence (RWE) Analytics (BPAHALAN)
- akta.pro secondary industries
- Real-World Evidence (RWE), HEOR & Epidemiology CROs (HLAGAAAK), Real-World Data (RWD) Platforms & Clinical Data Curation (HLACAIAJ), Real-World Evidence (RWE) & HEOR for Development (HLAIALAI), Clinical & Translational Informatics (Clinical Data Integration/Real-World Data for R&D) (HLAGAJAF)
Keywords
Where STATinMED is headquartered
LocationHeadquarters
- HQ city
- Dallas
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
STATinMED business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Technology or R&D, Marketing or Sales, Infrastructure, Operations
Revenue model
- Real-World Evidence Consulting Services: Professional consulting services providing real-world evidence generation, HEOR analysis, market access support, and strategic advisory services to healthcare and life science companies. Services are customized based on client research needs and delivered through project-based engagements.
- Data Access and Insights: Access to RWD Insights database and custom registry data products for evidence generation. Provides data lake advisory services to help clients develop ideal data infrastructure aligned with research goals.
Go-to-market motion2 records
Distribution channels1 record
Marketing channels6 records
STATinMED product offering
Product offeringCore offering
STATinMED delivers real-world evidence (RWE) consulting and proprietary all-payer medical and pharmacy claims data to pharmaceutical and life science companies. Its flagship offering combines the RWD Insights database (covering ~80% of the US healthcare system and 300+ million patient lives) with HEOR, Market Access, Clinical Operations, Medical Affairs, Data Advisory, and Peer-Reviewed Publication services. Engagements are customized to client research needs and delivered as project-based professional services engagements alongside licensed data access.
Product overview
STATinMED is a real-world evidence company offering a unified portfolio centered on its STATinMED RWD Insights data platform. The core offering includes the RWD Insights all-payer medical and pharmacy claims database covering over 300 million patient lives, supplemented by the RWD Custom Registry for tailored patient registries and RWD Insights Direct for enhanced analytics capabilities. The company provides a comprehensive suite of services including HEOR (Health Economics and Outcomes Research), Market Access, Clinical Operations Support, Medical Affairs Support, Data Advisory Services, and Peer-Reviewed Publication Services. Together, these products and services enable life science companies to discover real-world data, develop evidence-based insights, and deliver value through the product lifecycle from Phase II/III through post-launch.
Differentiator
Problem solved
Functional benefit
Brands
- RWD Insights: STATinMED's robust, licensed all-payer medical and pharmacy claims real-world data source covering over 80% of the US healthcare system
- RWD Custom Registry
- RWD Insights Direct
Products and services
- STATinMED RWD Insights Licensed all-payer medical and pharmacy claims real-world data platform capturing over 80% of the US healthcare system (300+ million patient lives), sourced from claims clearinghouses across all 50 states and updated monthly with a ~15-day delay. Licensed to healthcare and life science companies for real-world evidence generation.
- RWD Custom Registry Actionable, research-ready patient-level data product providing insights about patients with any disease and their treatment journey, including demographics, comorbidities, HCRU and costs, treatment utilization, HCP specialty, payer account, and time-varying metrics. Licensed to healthcare and life sciences clients for evidence generation.
- RWD Insights Direct Product offering designed to help healthcare companies enhance their real-world data capabilities, providing robust business intelligence from a team of analysts who understand client goals, delivered alongside a dedicated online portal.
- HEOR Services Health Economics and Outcomes Research services supporting product value demonstration from Phase II/III through post-launch, including unmet needs discovery, disease landscape mapping, epidemiology support, burden of illness measurement, comparative effectiveness, and value communication for pharmaceutical and life sciences clients.
- Market Access Services Data insights for product launch through commercialization, including clinical eligibility assessment, HCO-HCP insights, opportunity loss measurement, competitive indication share analysis, and payer-provider prioritization for pharmaceutical clients.
- Clinical Operations Support Services for clinical trial teams including study design prioritization and optimization, trial feasibility assessment, and patient and site selection using actionable, research-ready real-world data.
- Medical Affairs Support Accelerated safety assessments and regulatory response support leveraging curated real-world evidence insights to produce faster, more accurate outcomes for pharmaceutical medical affairs teams.
- Data Advisory Services Advisory and linkage services helping clients develop ideal data lakes sourced with curated data aligned with research goals, including data source identification, feasibility assessment, and analysis for healthcare companies.
- Peer-Reviewed Publication Services Writing and editing services for abstracts, posters, manuscripts, and presentations delivered by STATinMED's research team, with a track record of over 1,000 peer-reviewed publications across dozens of therapeutic areas.
Quantifiable outcome
- Captures approximately 80% of all US claims including medical and pharmacy across commercial, Medicaid & Medicare channels
- +2 more outcomes
Companies that use STATinMED
Customer profileNamed customers5 records
Segments3 records
Ideal customer profiles3 records
STATinMED technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature3 records
STATinMED partnerships and signals
Strategic signalScale indicators8 records
Recent moves5 records
Expansion highlights5 records
STATinMED competitors and assessment
Company assessmentDirect peers
- Trinity Life Sciences: Strategy and RWE consultancy focused on biopharma evidence generation, market access and launch. Comparable customer base, project-based delivery, and thought-leadership-driven marketing.
- Axtria: Data analytics and RWE firm serving pharma with proprietary data assets, HEOR, and commercial analytics. Comparable combination of consulting and productized data offerings, but at significantly larger scale.
- Evidera: Pure-play HEOR, market access and RWE consulting firm (now part of PPD/Thermo Fisher). Closest comparable to STATinMED in service mix, therapeutic breadth, and publication-led go-to-market.
- Real Chemistry: Data-driven health marketing, RWE and consulting firm working with pharma and life sciences. Overlaps with STATinMED in RWE analytics, healthcare AI applications, and biopharma client base.
Broad incumbents
- ICON plc: Global CRO offering RWE, HEOR and real-world data services alongside clinical operations. Competes for the same Top-25 pharma evidence-generation budgets and sponsors, with comparable full-lifecycle positioning.
- IQVIA: Largest global CRO and RWE platform with proprietary IQVIA claims, EHR and registry data. Directly comparable as a one-stop competitor for STATinMED's pharma RWE and HEOR engagements, but far larger and embedded across clinical and commercial.
- Symphony Health (an ICON company): Established US claims and patient-level data provider for pharma RWE and commercial analytics. Direct substitute for STATinMED's all-payer claims data use case from the buyer perspective.
- Optum (UnitedHealth Group): Owns one of the largest US commercial and Medicare claims data assets and serves biopharma with RWE, HEOR and market access services. Direct analogue to STATinMED's RWD Insights use cases, with far deeper payer integration.
Emerging players
- Komodo Health: Healthcare data platform layering de-identified patient journeys over US payer and provider data. Comparable to RWD Insights in dataset scope, but productized as software vs STATinMED's services-led delivery.
- Definitive Healthcare: Commercial intelligence and analytics platform over healthcare provider, claims and affiliation data. Adjacent competitor for the 'data + insights' wedge of STATinMED's portfolio with biopharma commercial users.
Market position
Strengths4 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights6 records
Customer concentration
STATinMED social profiles
Digital presenceSTATinMED compliance and trust
Trust signalCompliance3 records
STATinMED financial estimates
Financial estimateRevenue estimate
Valuation estimate
STATinMED leadership team
Management profileNumber of profiles
Profiles5 records
STATinMED funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
STATinMED M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about STATinMED
What does STATinMED do?
STATinMED delivers real-world evidence (RWE) consulting and proprietary all-payer medical and pharmacy claims data to pharmaceutical and life science companies. Its flagship offering combines the RWD Insights database (covering ~80% of the US healthcare system and 300+ million patient lives) with HEOR, Market Access, Clinical Operations, Medical Affairs, Data Advisory, and Peer-Reviewed Publication services. Engagements are customized to client research needs and delivered as project-based professional services engagements alongside licensed data access.
Is STATinMED a public or private company?
STATinMED is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was STATinMED founded?
STATinMED was founded in 2007. It employs 51 to 100 people.
Where is STATinMED based?
STATinMED is headquartered in Dallas, United States, in the North America region.
How does STATinMED make money?
Two revenue lines are on record. Real-World Evidence Consulting Services are the primary driver. The others are data Access and Insights.
Who are STATinMED's main competitors?
Direct peers on record are Trinity Life Sciences, Axtria, Evidera and Real Chemistry. Broad incumbents are ICON plc, IQVIA, Symphony Health (an ICON company) and Optum (UnitedHealth Group). Emerging players are Komodo Health and Definitive Healthcare.
Does STATinMED have an API?
No public API is recorded for STATinMED.
What industry is STATinMED in?
STATinMED's product category is Healthcare Real-World Evidence and HEOR Consulting. Its primary akta.pro industry code is BPAHALAN, Healthcare Outcomes & Real-World Evidence (RWE) Analytics, with a secondary code of HLAGAAAK, Real-World Evidence (RWE), HEOR & Epidemiology CROs. Its NAICS code is 54171 and its SIC code is 8090.